ACI
VRTX icon

Advance Capital I’s Vertex Pharmaceuticals VRTX Stock Holding History

Advance Capital I’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-20,100
Closed -$1.52M – 347
2013
Q3 		$1.52M Buy
20,100
+2,800
+16% +$223K 0.78% 4
2013
Q2 		$1.39M Buy
+17,300
New +$1.27M 0.68% 15

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Advance Capital I's VRTX Position: Q4 2013 in Review

Advance Capital I sold out of Vertex Pharmaceuticals (VRTX) in Q4 2013, closing a stake of 20,100 shares — an estimated $1.52M sold.

Advance Capital I first reported a position in VRTX in Q2 2013 and held it in 2 quarters. The position peaked at $1.52M in Q3 2013. 387 funds tracked by Wall St. Rank hold VRTX as of Q4 2013.

  • Advance Capital I reported no remaining Vertex Pharmaceuticals position as of Q4 2013 after selling out during the quarter.
  • Advance Capital I sold 20,100 Vertex Pharmaceuticals shares in Q4 2013, an estimated $1.52M.
  • Advance Capital I first reported a position in Vertex Pharmaceuticals in Q2 2013 and held it in 2 quarters.
  • Advance Capital I's Vertex Pharmaceuticals position peaked at $1.52M in Q3 2013.
  • 387 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2013.

Based on Advance Capital I's 13F filing for Q4 2013, filed 6 Feb 2014.